Have your own idea? Try our Stock Screener
Polish (WIG) Pharma Industry Analysis
UpdatedNov 21, 2024
DataAggregated Company Financials
Companies6
- 7D3.8%
- 3M-7.6%
- 1Y52.9%
- YTD38.4%
Last week, the Pharma industry hasn't moved much but Celon Pharma is up 3.0% in that time. The past year has been better, since the industry has gained 45% in that time. Earnings are forecast to grow by 67% annually.
Industry Valuation and Performance
Has the Polish Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 21 Nov 2024 | zł1.8b | zł316.0m | -zł73,254,489.00 | 11.6x | -24.2x | 5.6x |
| Sat, 19 Oct 2024 | zł2.0b | zł314.5m | -zł72,767,518.00 | 10.2x | -27.7x | 6.4x |
| Mon, 16 Sep 2024 | zł1.9b | zł317.3m | -zł60,178,104.00 | 12.8x | -31.1x | 5.9x |
| Wed, 14 Aug 2024 | zł1.8b | zł310.8m | -zł61,217,640.00 | 13.2x | -29.3x | 5.8x |
| Fri, 12 Jul 2024 | zł1.6b | zł310.8m | -zł61,217,640.00 | 11.9x | -25.9x | 5.1x |
| Sun, 09 Jun 2024 | zł1.1b | zł312.1m | -zł61,217,640.00 | 12.1x | -18.5x | 3.6x |
| Tue, 07 May 2024 | zł1.1b | zł310.9m | -zł43,157,065.00 | 14.1x | -26.3x | 3.6x |
| Thu, 04 Apr 2024 | zł1.2b | zł311.5m | -zł40,173,065.00 | 15.2x | -29x | 3.7x |
| Sat, 02 Mar 2024 | zł1.2b | zł311.5m | -zł40,173,065.00 | 15.1x | -29.5x | 3.8x |
| Mon, 29 Jan 2024 | zł1.2b | zł308.7m | -zł39,880,934.00 | 12.8x | -29.5x | 3.8x |
| Wed, 27 Dec 2023 | zł1.2b | zł308.7m | -zł39,880,934.00 | 11.7x | -29.9x | 3.9x |
| Fri, 24 Nov 2023 | zł1.1b | zł304.0m | -zł44,732,934.00 | 11x | -23.6x | 3.5x |
| Sun, 22 Oct 2023 | zł1.1b | zł302.0m | -zł42,933,291.00 | 11.2x | -26.4x | 3.7x |
| Tue, 19 Sep 2023 | zł1.2b | zł287.0m | -zł53,857,118.00 | 11.9x | -21.7x | 4.1x |
| Thu, 17 Aug 2023 | zł1.2b | zł287.1m | -zł53,836,279.00 | 11.1x | -21.9x | 4.1x |
| Sat, 15 Jul 2023 | zł1.2b | zł278.4m | -zł53,806,540.00 | 36.7x | -22.7x | 4.4x |
| Mon, 12 Jun 2023 | zł1.2b | zł282.0m | -zł51,275,141.00 | 36.1x | -23x | 4.2x |
| Wed, 10 May 2023 | zł1.1b | zł275.3m | -zł51,408,128.00 | 9.3x | -21.2x | 4x |
| Fri, 07 Apr 2023 | zł1.1b | zł273.2m | -zł44,427,333.00 | 8.9x | -25.7x | 4.2x |
| Sun, 05 Mar 2023 | zł1.1b | zł273.2m | -zł44,427,333.00 | 8.2x | -25.3x | 4.1x |
| Tue, 31 Jan 2023 | zł1.2b | zł270.3m | -zł44,201,704.00 | 8.1x | -26.3x | 4.3x |
| Thu, 29 Dec 2022 | zł945.6m | zł270.3m | -zł44,201,704.00 | 7.9x | -21.4x | 3.5x |
| Sat, 26 Nov 2022 | zł977.7m | zł270.9m | -zł44,399,510.00 | 7.6x | -22x | 3.6x |
| Mon, 24 Oct 2022 | zł861.1m | zł260.9m | -zł40,391,998.00 | 9.8x | -21.3x | 3.3x |
| Wed, 21 Sep 2022 | zł943.0m | zł265.6m | -zł29,272,739.00 | 9.4x | -32.2x | 3.6x |
| Fri, 19 Aug 2022 | zł1.2b | zł265.7m | -zł29,303,736.00 | 10.1x | -39.4x | 4.4x |
| Sun, 17 Jul 2022 | zł1.1b | zł264.2m | -zł29,985,890.00 | 10.5x | -36.9x | 4.2x |
| Tue, 14 Jun 2022 | zł1.2b | zł264.2m | -zł29,985,890.00 | 11.6x | -39.8x | 4.5x |
| Thu, 12 May 2022 | zł1.5b | zł236.1m | -zł2,279,146.00 | 56.8x | -678.4x | 6.5x |
| Sat, 09 Apr 2022 | zł1.8b | zł358.1m | zł72.0m | 12.9x | 24.6x | 4.9x |
| Mon, 07 Mar 2022 | zł1.6b | zł358.1m | zł72.0m | 12.4x | 22.4x | 4.5x |
| Wed, 02 Feb 2022 | zł2.1b | zł350.0m | zł71.4m | 16.1x | 29x | 5.9x |
| Fri, 31 Dec 2021 | zł2.3b | zł350.0m | zł71.4m | 13.1x | 31.9x | 6.5x |
| Sun, 28 Nov 2021 | zł2.2b | zł348.2m | zł81.0m | 13.5x | 27.3x | 6.4x |
Price to Earnings Ratio
27.3x
Current Industry PE
- Investors are optimistic on the Polish Pharmaceuticals industry, and appear confident in long term growth rates.
- The 3-year average PS ratio of 4.5x is lower than the industry's current PS ratio of 5.4x.
Past Earnings Growth
- Total earnings for the Pharmaceuticals industry have declined over the last three years, with the industry now making a loss overall.
- Revenues have also declined 3.2% per year, which is driving profits down.
Industry Trends
Which industries have driven the changes within the Polish Healthcare industry?
| PL Market | -3.15% | |
| Healthcare | -3.64% | |
| Pharma | 3.76% | |
| Pharma | 3.76% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| CLN Celon Pharma | zł27.45 | 3.0% +zł43.1m | 87.0% | PS7.1x | |
| MOC Molecure | zł11.30 | 17.7% +zł28.6m | -33.8% | PS125x | |
| CBD Cannabis Poland | zł0.48 | 0.4% +zł98.4k | 18.1% | PS88.3x |